Company / Working Capital per Share
Nuvation Bio Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.45
FY2025
5-year range
$1.45 / $3816.06
FY2021-FY2025
Trend
-32.2%
vs FY2024
Sector context
#170 of 210
Health Care
What the data says
Nuvation Bio Inc.'s working capital per share of $1.45 is lower than 81% of companies in the Health Care sector (FY2025). Working Capital per Share has declined for 4 consecutive years, from $3816.06 in FY2021 to $1.45 in FY2025.
Based on SEC 10-K filings.
1.45 in FY2025 with a 5-year CAGR of -8.0%.
Declined from $2752.47 to $1.45 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -92.2%
- 5-Year CAGR
- -8.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 210This company $1.45 Sector average $146.86
▼
-99.0% below sector average
Key checks
Key Insights
- Nuvation Bio Inc.'s working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 32.2% year-over-year.
- Ranks #170 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.45 | -32.2% |
| FY2024 | $2.14 | -99.9% |
| FY2023 | $2752.47 | -8.8% |
| FY2022 | $3018.43 | -20.9% |
| FY2021 | $3816.06 | +173708.7% |
| FY2020 | $2.20 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026